IDBR Infectious Disease Board Review

About IDBR Infectious Disease Board Review

The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification/recertification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams featuring over 500 ABIM-style and photo-based questions, and additional study guides and primers. https://www.idbrcourse.org/

Publisher

John Bennett, MD / Henry Masur, MD

Category

health & fitness

Language

en

Explicit

No

First episode

26 Apr 2024

Latest episode

9 Sept 2024

Latest episodes

22 episodes in the feed.

1. 

   9 Sept 2024

   Blood culture negative endocarditis - Trip Gulick, MD/ John Bennett, MD

   A 43-year-old man is admitted with acute onset of right sided hemiplegia and dysarthria. He had been in excellent health until one month previously when he presented with shortness of breath and was diagnosed with acute pulmonary emboli and adenocarcinoma of the lung. He was begun on eliquis and chemotherapy was deferred pending genetic testing. The patient lives with his wife and 2 children in Chicago. He works as a municipal bus driver. He denies pet or animal exposure. On presentation, he is afebrile. Exam is notable for poor dentition and dense right hemiplegia. CT head confirmed a left middle cerebral artery infarct. TTE confirms a 6x9 mm mass on the mitral valve. Blood cultures x3 sets taken prior to initiation of antibiotics are no growth at 5 days. What is the most probable cause of endocarditis in this patient? A. T whipplei B. Mycobacterium chimaera C. Bartonella henselae D. Hypercoaguable state E. Coxiella burnetii ⁠www.idbrcourse.org/⁠ (https://www.idbrcourse.org/)  © 2024 IDBR LLC | All Rights Reserved

2. 

   2 Sept 2024

   Preventing HIV with antiretrovirals - Trip Gulick, MD/ Trip Gulick, MD

   A 58-year-old HIV- negative gay man is evaluated for PrEP. His past medical history is notable for hypertension, treated for over 10 years with an ACE inhibitor. He is asymptomatic and weighs 145 lbs. He is sexually active with multiple partners but “usually” practices safe sex. Lab studies reveal: HIV 4th generation test negative, HIV-1 RNA negative, CBC normal, creatinine 1.4 with a calculated creatinine clearance of 48 ml/min. What do you recommend for PrEP? A. No PrEP B. Tenofovir disoproxil fumarate/emtricitabine 1 pill daily C. Tenofovir disoproxil fumarate/emtricitabine 1 pill every other day D. Tenofovir alafenamide/emtricitabine 1 pill daily ⁠www.idbrcourse.org/⁠ (https://www.idbrcourse.org/)  © 2024 IDBR LLC | All Rights Reserved

3. 

   26 Aug 2024

   Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD

   A 44-year-old man was diagnosed with Pneumocystis pneumonia as his AIDS-defining illness and begun on antiretroviral therapy with 2 nucleosides and an integrase inhibitor during his hospitalization. He stabilizes and follows up for repeated outpatient visits with an HIV RNA consistently <20 copies/ml and a CD4 cell count of 44 that increased to 163 (at 3 months), 232 (at 6 months), 242 (at 9 months), and was repeated at 243 (at 12 months). His current medications are: tenofovir alafenamide/emtricitabine, dolutegravir, trimethoprim-sulfa double strength daily, and azithromycin 1200 mg once weekly. He says he’s tired of taking pills and would like to stop some of them. What do you recommend? A. Stop tenofovir alafenamide/emtricitabine B. Stop trimethoprim-sulfa C. Stop azithromycin D. Stop trimethoprim-sulfa and azithromycin E. Continue the current regimen ⁠www.idbrcourse.org/⁠ (https://www.idbrcourse.org/)  © 2024 IDBR LLC | All Rights Reserved

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

2 ratings

Spotify

5.0 / 5

1 ratings